Oral viral infections of children

Periodontology 2000

Volumn 49, Issue 1, 2009, Pages 87-95

  Sällberg, Matti ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; GROWTH, DEVELOPMENT AND AGING; HEPATITIS VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; INFANT; MEASLES VIRUS; MOUTH DISEASE; MUMPS VIRUS; PAPILLOMA VIRUS; PATHOGENICITY; PRESCHOOL CHILD; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HEPATITIS VIRUSES; HERPESVIRIDAE; HIV-1; HUMANS; IMMUNE SYSTEM; INFANT; MORBILLIVIRUS; MOUTH DISEASES; MUMPS VIRUS; PAPILLOMAVIRIDAE; VIRUS DISEASES;

EID: 57849136549     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2008.00277.x     Document Type: Article

References (50)

1. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis 2004 : 4 : 91 99.
2. Bartenschlager R. Hepatitis C virus replicons: potential role for drug development. Nat Rev Drug Discov 2002 : 1 : 911 916.
3. Bible JM, Pantelidis P, Chan PK, Tong CY. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev Med Virol 2007 : 17 : 371 379.
4. Bonderoff JM, Lloyd RE. CVB translation: lessons from the polioviruses. Curr Top Microbiol Immunol 2008 : 323 : 123 147.
5. Broderick AL, Jonas MM. Hepatitis B in children. Semin Liver Dis 2003 : 23 : 59 68.
6. Camain R, Koerber R, Mazaud R. [Isolation of a Coxsackie-type virus from a case of epidemic aphthoid stomatitis.]. Bull Soc Pathol Exot Filiales 1956 : 49 : 698 704.
7. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999 : 354 : 1682 1686.
8. Chen MT, Billaud JN, Sallberg M, Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A 2004 : 101 : 14913 14918.
9. Deeks SG. Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet 2003 : 362 : 2002 2011.
10. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008 : 21 : 198 208.
11. Desselberger U. Herpes simplex virus infection in pregnancy: diagnosis and significance. Intervirology 1998 : 41 : 185 190.
12. Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet 2003 : 361 : 763 773.
13. Elisofon SA, Jonas MM. Hepatitis B and C in children: current treatment and future strategies. Clin Liver Dis 2006 : 10 : 133 148, vii.
14. Fields BN, Knipe DM, Howley PM. Fields virology, 4th edn. Philadelphia, USA : Raven, 2001.
15. Fischler B. Hepatitis C virus infection. Semin Fetal Neonatal Med 2007 : 12 : 168 173.
16. Gallegos AM, Bevan MJ. Central tolerance: good but imperfect. Immunol Rev 2006 : 209 : 290 296.
17. Giovannelli L, Campisi G, Lama A, Giambalvo O, Osborn J, Margiotta V, Ammatuna P. Human papillomavirus DNA in oral mucosal lesions. J Infect Dis 2002 : 185 : 833 836.
18. Hambleton S, Gershon AA. Preventing varicella-zoster disease. Clin Microbiol Rev 2005 : 18 : 70 80.
19. Hedner E, Vahlne A, Hirsch JM. Primary herpes simplex virus (type 1) infection delays healing of oral excisional and extraction wounds in the rat. J Oral Pathol Med 1990 : 19 : 471 476.
20. Hedner E, Vahlne A, Kahnberg KE, Hirsch JM. Reactivated herpes simplex virus infection as a possible cause of dry socket after tooth extraction. J Oral Maxillofac Surg 1993 : 51 : 370 376 (discussion 377-378).
21. Heininger U, Seward JF. Varicella. Lancet 2006 : 368 : 1365 1376.
22. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995 : 373 : 123 126.
23. Hviid A., Rubin S, Muhlemann K. Mumps. Lancet 2008 : 371 : 932 944.
24. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004 : 132 : 1005 1022.
25. Joura EA, Leodolter S, Hernandez M-Avila, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007 : 369 : 1693 1702.
26. Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect 2006 : 12 : 202 211.
27. Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 2006 : 1 : 375 404.
28. Lin SS, Chou MY, Ho CC, Kao CT, Tsai CH, Wang L, Yang CC. Study of the viral infections and cytokines associated with recurrent aphthous ulceration. Microbes Infect 2005 : 7 : 635 644.
29. MacArthur RD, Novak RM, Peng G, Chen L, Xiang Y, Hullsiek KH, Kozal MJ, van den Berg-Wolf M, Henely C, Schmetter B, Dehlinger M. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. Lancet 2006 : 368 : 2125 2135.
30. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006 : 118 : 137 144.
31. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 1990 : 87 : 6599 6603.
32. Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC, Bolognesi D, Barry DW, Broder S. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A 1985 : 82 : 7096 7100.
33. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, Chen DS. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007 : 132 : 1287 1293.
34. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007 : 369 : 2161 2170.
35. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst Rev 2006 : 3 : CD003940.
36. Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet 2007 : 370 : 68 80.
37. Sauerbrei A, Wutzler P. The congenital varicella syndrome. J Perinatol 2000 : 20 : 548 554.
38. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007 : 370 : 890 907.
39. Schneider-Schaulies J, Meulen V, Schneider-Schaulies S. Measles infection of the central nervous system. J Neurovirol 2003 : 9 : 247 252.
40. Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity 2008 : 28 : 18 28.
41. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, Hall AJ. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004 : 364 : 963 969.
42. Sokal EM, Kelly DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Vegnente A, Little NR, Gardener SD, Jonas MM. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006 : 43 : 225 232.
43. Sprent J. Proving negative selection in the thymus. J Immunol 2005 : 174 : 3841 3842.
44. Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007 : 6 : 1015 1028.
45. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002 : 360 : 678 682.
46. Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007 : 357 : 1281 1292.
47. Tierney LM Jr., Wang KC. Images in clinical medicine. Koplik's spots. N Engl J Med 2006 : 354 : 740.
48. Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 2004 : 6 : 1 16.
49. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996 : 272 : 537 542.
50. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994 : 343 : 955 957.